Briakinumab Antibody is a research-grade biosimilar monoclonal antibody targeting IL-12 subunit p40. It is a human IgG1-lambda antibody. Reactivity: Human. Supplied as a liquid in 0.01M PBS pH 7.4. Applications: ELISA, flow cytometry, functional assays and in vivo research. Endotoxin: < 10 EU/mg. Purity: >95% as determined by SDS-PAGE. For research use only.
Interleukin-12 subunit beta (IL-12 subunit p40,IL12B,Interleukin-12 subunit beta,IL-12B,CLMF p40,NKSF2,NK cell stimulatory factor chain 2,Cytotoxic lymphocyte maturation factor 40 kDa subunit) is a ~37 kDa protein. Cytokine that can act as a growth factor for activated T and NK cells, enhance the lytic activity of NK/lymphokine-activated killer cells, and stimulate the production of IFN-gamma by resting PBMC.
Product Name:
Briakinumab Antibody
SKU:
GXBS00011
Size:
100 µg, 1 mg
Antibody Type:
Monoclonal Antibody
Target:
IL-12 subunit p40
Isotype:
IgG1-lambda
Host Species:
Human
Reactivity:
Human
Applications:
ELISA, FACS, Functional assay, Research in vivo
Expression Host:
Mammalian cells
Synonyms:
ABT-874, J695, 339308-60-0
Purity:
>95% as determined by SDS-PAGE.
Endotoxin Level:
< 10 EU/mg
Formulation:
0.01M PBS pH 7.4
State of Matter:
Liquid
Regulatory Status:
For research use only. Not suitable for clinical or therapeutic use.
Product Preparation:
Protein A/G purified from cell culture supernatant.
Storage and Handling:
Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
